Randomized Split-Face Study to Assess the Efficacy and Safety of AbobotulinumtoxinA Versus OnabotulinumtoxinA in the Treatment of Melomental Folds (Depressor Anguli Oris).
Goldman, Butterwick, Fitzpatrick, Groff & Fabi: Cosmetic Laser Dermatology, Department of Dermatology University of California San Diego School of Medicine San Diego, California Goldman, Butterwick, Fitzpatrick, Groff & Fabi: Cosmetic Laser Dermatology, San Diego, California Goldman, Butterwick, Fitzpatrick, Groff & Fabi: Cosmetic Laser Dermatology, San Diego, California Volunteer Clinical Professor of Dermatology/Medicine, University of California, San Diego, California.
Sabrina G
SG
Fabi
Ane N
AN
Massaki
Isabella
I
Guiha
Mitchel P
MP
Goldman
D000328:Adult; D000368:Aged; D019274:Botulinum Toxins, Type A / Q000009:adverse effects / Q000627:therapeutic use*; D003357:Cosmetic Techniques; D005149:Facial Expression; D005152:Facial Muscles / Q000187:drug effects*; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008875:Middle Aged; D009055:Mouth; D009465:Neuromuscular Agents / Q000009:adverse effects / Q000627:therapeutic use*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A; C545476:incobotulinumtoxinA